Multi-center, randomized, open-label, parallel group study of a vaginal micronized progesterone tablet (Endometrin[R]) [FE 999913; Ferring] compared to crinone [progesterone] 8% vaginal gel in female patients undergoing in-vitro fertilization (IVF).

Trial Profile

Multi-center, randomized, open-label, parallel group study of a vaginal micronized progesterone tablet (Endometrin[R]) [FE 999913; Ferring] compared to crinone [progesterone] 8% vaginal gel in female patients undergoing in-vitro fertilization (IVF).

Completed
Phase of Trial: Phase III

Latest Information Update: 18 May 2011

At a glance

  • Drugs Progesterone (Primary)
  • Indications Female infertility; Infertility
  • Focus Therapeutic Use
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 01 Apr 2009 Results published in Fertility and Sterility.
    • 17 Feb 2009 Actual end date reported as 1 May 2006 by ClinicalTrials.gov.
    • 25 Jun 2007 Results have been reported.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top